Steven C. Bishop

Array ( [id] => 5141324 [patent_doc_number] => 20070003540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Stem cells having increased sensitivity to sdf-1 and methods of generating and using same' [patent_app_type] => utility [patent_app_number] => 10/552299 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14809 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003540.pdf [firstpage_image] =>[orig_patent_app_number] => 10552299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938535 [patent_doc_number] => 20050112098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Pseudotyped viruses and methods for their use' [patent_app_type] => utility [patent_app_number] => 10/811353 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 32794 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112098.pdf [firstpage_image] =>[orig_patent_app_number] => 10811353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101864 [patent_doc_number] => 07727761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/792480 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 39828 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/727/07727761.pdf [firstpage_image] =>[orig_patent_app_number] => 10792480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4486260 [patent_doc_number] => 07902421 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Animal model for schizophrenia' [patent_app_type] => utility [patent_app_number] => 10/547346 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 7675 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902421.pdf [firstpage_image] =>[orig_patent_app_number] => 10547346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8410172 [patent_doc_number] => 08273568 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Replication-competent herpes simplex virus mediates destruction of neoplastic cells' [patent_app_type] => utility [patent_app_number] => 10/788410 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14176 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10788410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119315 [patent_doc_number] => 20070141029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Methods of gene therapy for treating disorders of the ear by adminstering a vector encoding an antonal-associated factor' [patent_app_type] => utility [patent_app_number] => 10/586072 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17443 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141029.pdf [firstpage_image] =>[orig_patent_app_number] => 10586072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5690116 [patent_doc_number] => 20060288431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells' [patent_app_type] => utility [patent_app_number] => 10/545368 [patent_app_country] => US [patent_app_date] => 2004-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 43760 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20060288431.pdf [firstpage_image] =>[orig_patent_app_number] => 10545368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7313080 [patent_doc_number] => 20040143869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Methods of identifying compounds that induce expression of glutathione S-transferase' [patent_app_type] => new [patent_app_number] => 10/776956 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15690 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143869.pdf [firstpage_image] =>[orig_patent_app_number] => 10776956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7316687 [patent_doc_number] => 20040223960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases' [patent_app_type] => new [patent_app_number] => 10/776797 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10018 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20040223960.pdf [firstpage_image] =>[orig_patent_app_number] => 10776797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7183820 [patent_doc_number] => 20040203153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made' [patent_app_type] => new [patent_app_number] => 10/770418 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9240 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203153.pdf [firstpage_image] =>[orig_patent_app_number] => 10770418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5674147 [patent_doc_number] => 20060179502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Automated gene-targeting using non-toxic detectable markers' [patent_app_type] => utility [patent_app_number] => 10/544683 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8158 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20060179502.pdf [firstpage_image] =>[orig_patent_app_number] => 10544683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136524 [patent_doc_number] => 20050181374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Kruppel-like factor 6 ( KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein' [patent_app_type] => utility [patent_app_number] => 10/752079 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26435 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181374.pdf [firstpage_image] =>[orig_patent_app_number] => 10752079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7264731 [patent_doc_number] => 20040151697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Replication-competent herpes simplex virus mediates destruction of neoplastic cells' [patent_app_type] => new [patent_app_number] => 10/748233 [patent_app_country] => US [patent_app_date] => 2003-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14238 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20040151697.pdf [firstpage_image] =>[orig_patent_app_number] => 10748233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409658 [patent_doc_number] => 20040176293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof' [patent_app_type] => new [patent_app_number] => 10/740218 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26451 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176293.pdf [firstpage_image] =>[orig_patent_app_number] => 10740218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473990 [patent_doc_number] => 20040097414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Human fgf23 protein mutants lowering blood phosphorus level' [patent_app_type] => new [patent_app_number] => 10/451942 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9955 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097414.pdf [firstpage_image] =>[orig_patent_app_number] => 10451942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220554 [patent_doc_number] => 20040072259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Methods and products for manipulating hematopoietic stem cells' [patent_app_type] => new [patent_app_number] => 10/433146 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22069 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072259.pdf [firstpage_image] =>[orig_patent_app_number] => 10433146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4525235 [patent_doc_number] => 07951923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Fluorescent proteins and chromoproteins from non-Aequorea hydrozoa species and methods for using same' [patent_app_type] => utility [patent_app_number] => 10/532681 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 13586 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951923.pdf [firstpage_image] =>[orig_patent_app_number] => 10532681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427861 [patent_doc_number] => 20040161753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Creation and identification of proteins having new dna binding specificities' [patent_app_type] => new [patent_app_number] => 10/416708 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24926 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161753.pdf [firstpage_image] =>[orig_patent_app_number] => 10416708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835360 [patent_doc_number] => 20060247191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Chimeric cytoplasmic signalling molecules' [patent_app_type] => utility [patent_app_number] => 10/533003 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10430 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247191.pdf [firstpage_image] =>[orig_patent_app_number] => 10533003 [rel_patent_id] =>[rel_patent_doc_number] =>)